Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06293560 · ClinicalTrials.gov registry record
Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children
A clinical trial of Coloboma and Anophthalmia, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT06293560: Recruiting study of Coloboma and Anophthalmia, sponsored by Baylor College of Medicine.
NCT06293560 is a study of Coloboma and Anophthalmia that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 3,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06293560, a study of Coloboma and Anophthalmia, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are inviting families to take part in a research study that will help us better understand the physical characteristics associated with children who have Microphthalmia, Anophthalmia, and Coloboma (MAC) and how changes in their DNA sequence, called genetic mutations, play a role in the risk of developing MAC
Primary Outcome
We are conducting interviews to collect detailed pregnancy, medical and family histories; review medical records to identify cases with chromosomal abnormalities or other syndromic diagnosis (that were not identified by the TBDR) and associated malformations, as well as to assess clinical course; and collect saliva samples that may be used to extract DNA to be analyzed for genetic mutations.
Conditions Studied
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2022-09-25 |
| Est. Completion | 2027-09 |
What NCT06293560 shows while recruiting
NCT06293560 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 3 conditions, with Coloboma appearing as the primary indexed condition, and to 0 interventions.
NCT06293560 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06293560 about?
NCT06293560 is a clinical study titled "Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children". The investigators are inviting families to take part in a research study that will help us better understand the physical characteristics associated with children who have Microphthalmia, Anophthalmia, and Coloboma (MAC) and how changes in their DNA sequence, called genetic mutations, play a role in...
What is the current status of trial NCT06293560?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2022-09-25. Estimated completion is 2027-09.
What conditions does trial NCT06293560 study?
This clinical trial studies the following conditions: Coloboma, Anophthalmia, Microphthalmia.
Who is sponsoring clinical trial NCT06293560?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06293560 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coloboma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI